Collaborators

Canary Foundation at Stanford

The Canary Center at Stanford is the first research centre in the US dedicated uniquely to cancer early detection programs. The Canary Center's main research areas include: cancer biomarker discovery and validation, development of novel technologies and point-of-care diagnostics, mathematical modeling of cancer, development of new imaging techniques and molecular imaging probes, and translation of new diagnostic approaches into clinical trials.

Through two exchange visits in 2017 the Early Detection Programme and the Canary Center have established a long-term collaborative relationship to combine outstanding academic and clinical researchers from the UK and US to tackle some of the most challenging questions in detecting cancer earlier. 

In 2018 the Canary Center and the CRUK Cambridge Centre Early Detection programme announced a pioneering transatlantic collaboration to fund four joint research projects exploring innovative ways to detect prostate, lung, oesophageal and renal cancers at an early stage.

For a video of the announcement of the awards and project overview of the collaborators see here: 


Oregon Health & Science University (OHSU)

In 2016, The Knight Cancer Institute at Oregon Health & Science University, a leader in precision cancer medicine, and Cancer Research UK, the largest independent funder of cancer research globally, formed an international collaboration to accelerate research in the early detection of cancer.

The goal of this unique trans-Atlantic agreement is to find lethal cancers as they’re forming so they can be treated more effectively. Survival increases significantly when the disease is treated at an early stage.

An annual early detection conference is jointly organised by both institutions. In 2017 the conference was hosted in Cambridge, UK.